These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22245952)

  • 1. Good response to infliximab in a patient with deep vein thrombosis associated with Behçet disease.
    Yoshida S; Takeuchi T; Yoshikawa A; Ozaki T; Fujiki Y; Hata K; Makino S; Hanafusa T
    Mod Rheumatol; 2012 Sep; 22(5):791-5. PubMed ID: 22245952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.
    Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Hanami K; Tanaka Y
    Mod Rheumatol; 2011 Apr; 21(2):184-91. PubMed ID: 21052764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis.
    Adler S; Baumgartner I; Villiger PM
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):607-11. PubMed ID: 22162223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
    Tabbara KF; Al-Hemidan AI
    Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome.
    Ozguler Y; Hatemi G; Cetinkaya F; Tascilar K; Hamuryudan V; Ugurlu S; Seyahi E; Yazici H; Melikoglu M
    Rheumatology (Oxford); 2020 Apr; 59(4):799-806. PubMed ID: 31504957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of anti-tumor necrosis factor α monoclonal antibodies in 16 patients with severe/refractory vasculo Behcet's disease].
    Li L; Liu JJ; Yu X; Wu D; Zhang SZ; Yang YJ; Zhou JX; Zeng XF; Zhang FC; Zheng WJ
    Zhonghua Nei Ke Za Zhi; 2020 Apr; 59(4):303-308. PubMed ID: 32209197
    [No Abstract]   [Full Text] [Related]  

  • 7. Infliximab in refractory uveitis due to Behçet's disease.
    Wechsler B; Sablé-Fourtassou R; Bodaghi B; Huong DL; Cassoux N; Badelon I; Fain O; LeHoang P; Piette JC
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet disease.
    Ribi C; Sztajzel R; Delavelle J; Chizzolini C
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1733-5. PubMed ID: 16291906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of recurrent uveitis with TNF-alpha inhibitors].
    Falappone PC; Iannone F; Scioscia C; Grattagliano V; Covelli M; Lapadula G
    Reumatismo; 2004; 56(3):185-9. PubMed ID: 15470524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary artery involvement in Behçet׳s syndrome: Effects of anti-Tnf treatment.
    Hamuryudan V; Seyahi E; Ugurlu S; Melikoglu M; Hatemi G; Ozguler Y; Akman C; Tuzun H; Yurdakul S; Yazici H
    Semin Arthritis Rheum; 2015 Dec; 45(3):369-73. PubMed ID: 26190564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease.
    Yamada Y; Sugita S; Tanaka H; Kamoi K; Kawaguchi T; Mochizuki M
    Br J Ophthalmol; 2010 Mar; 94(3):284-8. PubMed ID: 19692382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid in Combination with a TNF-α Inhibitor: Treatment of Deep Vein Thrombosis in a Patient with Behçet's Disease.
    Okano M; Yoneda K; Ichise Y; Kusuhara S; Muramae N; Mori K; Otsui K; Sakaguchi K
    Intern Med; 2023 Jul; 62(13):2009-2012. PubMed ID: 36384897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients.
    Desbois AC; Biard L; Addimanda O; Lambert M; Hachulla E; Launay D; Ackermann F; Pérard L; Hot A; Maurier F; Mausservey C; Bernard F; Noel N; Alric L; Mirault T; Cohen F; Boussouar S; Resche-Rigon M; Cacoub P; Saadoun D
    Clin Immunol; 2018 Dec; 197():54-59. PubMed ID: 30125675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of current management of vasculo-Behcet's.
    Merashli M; Eid RE; Uthman I
    Curr Opin Rheumatol; 2018 Jan; 30(1):50-56. PubMed ID: 29076891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis.
    Catanoso MG; Spaggiari L; Magnani L; Pipitone N; Versari A; Boiardi L; Pazzola G; Pattacini P; Salvarani C
    Clin Exp Rheumatol; 2012; 30(5):776-8. PubMed ID: 23021007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet disease.
    Giansanti F; Barbera ML; Virgili G; Pieri B; Emmi L; Menchini U
    Eur J Ophthalmol; 2004; 14(5):445-8. PubMed ID: 15506610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life-threatening vasculo-Behçet following discontinuation of infliximab after three years of complete remission.
    Magro-Checa C; Salvatierra J; Rosales-Alexander JL; Orgaz-Molina J; Raya-Álvarez E
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):96-8. PubMed ID: 23739315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.